Parallel Advisors, LLC

SEC CIK: 0001690010
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

TCRR holding history

TCR2 Therapeutics Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCRR overview All 13F holders of TCRR Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 4; Since Q1 2021

Holdings of TCRR by Parallel Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−10−100.0%	Sold out	Holders
Q4 2021	10	$0	0.0%	00.0%	Unchanged	Holders
Q3 2021	10	$0	0.0%	+6+150.0%	Added	Holders
Q2 2021	4	$0	0.0%	00.0%	Unchanged	Holders
Q1 2021	4	$0	0.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.